A detailed history of Jane Street Group, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Jane Street Group, LLC holds 16,261 shares of ASND stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,261
Previous 20,394 20.27%
Holding current value
$2.02 Million
Previous $3.08 Million 28.07%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$121.07 - $153.67 $500,382 - $635,118
-4,133 Reduced 20.27%
16,261 $2.22 Million
Q1 2024

May 15, 2024

SELL
$123.45 - $159.4 $1.37 Million - $1.77 Million
-11,074 Reduced 35.19%
20,394 $3.08 Million
Q4 2023

Feb 14, 2024

BUY
$86.1 - $127.36 $581,261 - $859,807
6,751 Added 27.31%
31,468 $3.96 Million
Q3 2023

Nov 14, 2023

SELL
$86.5 - $103.97 $4.3 Million - $5.17 Million
-49,698 Reduced 66.78%
24,717 $2.31 Million
Q2 2023

Aug 14, 2023

BUY
$69.96 - $97.84 $4.2 Million - $5.88 Million
60,082 Added 419.19%
74,415 $6.64 Million
Q1 2023

May 15, 2023

SELL
$104.9 - $126.78 $4.04 Million - $4.89 Million
-38,560 Reduced 72.9%
14,333 $1.54 Million
Q4 2022

Feb 14, 2023

SELL
$99.42 - $131.97 $1.83 Million - $2.43 Million
-18,392 Reduced 25.8%
52,893 $6.46 Million
Q3 2022

Nov 14, 2022

BUY
$84.03 - $110.23 $2.58 Million - $3.39 Million
30,731 Added 75.78%
71,285 $7.36 Million
Q3 2022

Nov 14, 2022

BUY
$84.03 - $110.23 $2.58 Million - $3.39 Million
30,731 Added 75.78%
71,285 $7.36 Million
Q2 2022

Aug 16, 2022

BUY
$78.08 - $117.61 $942,581 - $1.42 Million
12,072 Added 42.38%
40,554 $3.77 Million
Q1 2022

May 17, 2022

BUY
$102.18 - $135.75 $1.42 Million - $1.88 Million
13,861 Added 94.8%
28,482 $3.34 Million
Q4 2021

Feb 15, 2022

BUY
$127.1 - $169.66 $1.01 Million - $1.35 Million
7,936 Added 118.71%
14,621 $1.97 Million
Q3 2021

Nov 16, 2021

BUY
$112.67 - $176.92 $277,618 - $435,930
2,464 Added 58.37%
6,685 $1.07 Million
Q1 2021

May 18, 2021

BUY
$124.92 - $173.33 $33,353 - $46,279
267 Added 6.75%
4,221 $544,000
Q4 2020

Feb 17, 2021

SELL
$151.2 - $182.76 $5.11 Million - $6.17 Million
-33,769 Reduced 89.52%
3,954 $659,000
Q3 2020

Nov 17, 2020

SELL
$134.29 - $154.32 $385,412 - $442,898
-2,870 Reduced 7.07%
37,723 $5.82 Million
Q2 2020

Aug 17, 2020

BUY
$110.87 - $156.01 $4.5 Million - $6.33 Million
40,593 New
40,593 $6 Million
Q3 2019

Nov 14, 2019

SELL
$95.8 - $118.9 $519,236 - $644,438
-5,420 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$107.11 - $132.09 $580,536 - $715,927
5,420 New
5,420 $624,000
Q2 2018

Aug 15, 2018

SELL
$58.55 - $73.92 $223,485 - $282,152
-3,817 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$38.98 - $68.04 $148,786 - $259,708
3,817 New
3,817 $250,000
Q4 2017

Feb 15, 2018

SELL
$31.98 - $40.38 $310,333 - $391,847
-9,704 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$26.89 - $37.1 $260,940 - $360,018
9,704
9,704 $352,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.94B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.